MOG and COVID-19: Recent studies (17) reveal elevated levels of brain-reactive autoantibodies against MBP, MOG, tubulin, CP2, and synaptophysin in patients suffering from protracted COVID-19, suggesting a possible involvement of neuroautoimmune pathophysiology.